Complete Pathological Response to Neoadjuvant Treatment in Pancreatic Ductal Adenocarcinoma-Can We Achieve a Long-Term Survival? A Narrative Review. [PDF]
Gajda M +4 more
europepmc +1 more source
Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade. [PDF]
Ciccone DN +7 more
europepmc +1 more source
Impact of a "Digital Health" Curriculum on Students' Perception About Competence and Relevance of Digital Health Topics for Future Professional Challenges: Prospective Pilot Study. [PDF]
Kröplin J, Maier L, Lenz JH, Romeike B.
europepmc +1 more source
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer. [PDF]
Porter R +20 more
europepmc +1 more source
An update on the immune landscape in lung and head and neck cancers
Ca-A Cancer Journal for Clinicians, 2020Jennifer W Carlisle +2 more
exaly
Emerging connectivity of programmed cell death pathways and its physiological implications
Nature Reviews Molecular Cell Biology, 2020Sammy Bedoui +2 more
exaly
Hodgkin lymphoma: A review and update on recent progress
Ca-A Cancer Journal for Clinicians, 2018Satish P Shanbhag, Richard F Ambinder
exaly
HPV Communication: Review of Existing Research and Recommendations for Patient Education
Ca-A Cancer Journal for Clinicians, 2004Annekathryn Goodman
exaly

